Dennis Kim, CMO at Larimar Therapeutics, holds 0.00 shares in Larimar Therapeutics (Ticker: LRMR), holds ― shares in Skye Bioscience (Ticker: SKYE), holds 20.00K shares in CymaBay Therapeutics (Ticker: CBAY). Most recently, Dennis Kim Bought ― shares of Larimar Therapeutics on Jul 12, 2017 for an estimated value of 33.90K.